Evidence map›Paper›PMID 29895317›Full record

ArticleStem cell research & therapy2018

Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34

Dewan Zhao, Lingjia Liu, Qiang Chen, Fangfang Wang, Qiuyang Li, Qiang Zeng, Jingcao Huang, Maowen Luo, Wenxian Li, Yuhuan Zheng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Effect ofFrontiers in microbiology · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Mesenchymal Stem Cells Application in Wound Tissue Healing in Old Animals.Stem cells and cloning : advances and applications · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Dewan ZhaoDepartment of Hematology, Hematology Research Laboratory, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Lingjia LiuDepartment of Hematology, Hematology Research Laboratory, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Qiang ChenSichuan Cord Blood Stem Cell Bank, Chengdu, Sichuan, People's Republic of China.
Fangfang WangDepartment of Hematology, Hematology Research Laboratory, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Qiuyang LiDepartment of Hematology, Hematology Research Laboratory, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Qiang ZengDepartment of Hematology, Hematology Research Laboratory, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Jingcao HuangDepartment of Hematology, Hematology Research Laboratory, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Maowen LuoSichuan Cord Blood Stem Cell Bank, Chengdu, Sichuan, People's Republic of China.
Wenxian LiSichuan Cord Blood Stem Cell Bank, Chengdu, Sichuan, People's Republic of China.
Yuhuan ZhengDepartment of Hematology, Hematology Research Laboratory, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Ting LiuDepartment of Hematology, Hematology Research Laboratory, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China. liuting@scu.edu.cn.ORCID 0000-0003-1816-5551
Sichuan University · CNCell Technology (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe physiological approach suggests that an environment associating mesenchymal stromal cells with low O

methodsCD34

resultsOur results showed that the number of TNC cells, CD34

conclusionsOur data demonstrate that cord blood HSPCs maintain stemness better under hypoxia than normoxia with WJ-MSC coculture, partially due to the increased secretion of VEGF, decreased secretion of IL-6 by WJ-MSCs, and selective activation of stem cell signal pathways in HSPCs. This suggests that the oxygenation may not only be a physiological regulatory factor but also a cell engineering tool in HSPC research, and this may have important translational and clinical implications.

Indexed as

Antigens, CD34Cell DifferentiationCell HypoxiaCell ProliferationCells, CulturedCoculture TechniquesFetal BloodHumansMesenchymal Stem CellsWharton JellyAntigens, CD34Ex vivo HSPC expansionHypoxic cocultureWharton’s jelly mesenchymal stem cells

Identifiers

PMID29895317
PMCPMC5998541
OpenAlexW2807729516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.